CCN(CC)CCN1C(=O)C2C(C(=O)Nc3cc(C)cc(C)c3)C3C=CC2(O3)C1C(=O)NC1CCCCC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?